Literature DB >> 22563775

The undiagnosed cases of Clostridium difficile infection in a whole nation: where is the problem?

L Alcalá1, A Martín, M Marín, M Sánchez-Somolinos, P Catalán, T Peláez, E Bouza.   

Abstract

Underdiagnosis of Clostridium difficile infection (CDI) because of lack of clinical suspicion or the use of non-sensitive diagnostic techniques is a known problem whose real magnitude has not yet been quantified. In order to estimate the extent of this underdiagnosis, we performed C. difficile cultures on all unformed stool specimens sent-irrespective of the type of request-to a series of laboratories in Spain on a single day. The specimens were cultured, and isolates were characterized at a central reference laboratory. A total of 807 specimens from 730 patients aged ≥ 2 years were selected from 118 laboratories covering 75.4% of the Spanish population. The estimated rate of hospital-acquired CDI was 2.4 episodes per 1000 admissions or 3.8 episodes per 10,000 patient-days. Only half of the episodes occurred in patients hospitalized for >2 days. Two of every three episodes went undiagnosed or were misdiagnosed, owing to non-sensitive diagnostic tests (19.0%) or lack of clinical suspicion and request (47.6%; mostly young people or non-hospitalized patients). The main ribotypes were 014/020 (20.5%), 001 (18.2%), and 126/078 (18.2%). No ribotype 027 strains were detected. Strains were fully susceptible to metronidazole and vancomycin. CDI was underdiagnosed in diarrhoeic stools in a high proportion of episodes, owing to the use of non-sensitive techniques or lack of clinical suspicion, particularly in people aged <65 years or patients with community-acquired diarrhoea. C. difficile toxins should be routinely sought in unformed stools of any origin sent for microbiological diagnosis. The ribotype 027 clone has not yet disseminated in Spain.
© 2012 The Authors. Clinical Microbiology and Infection © 2012 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Year:  2012        PMID: 22563775     DOI: 10.1111/j.1469-0691.2012.03883.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  25 in total

1.  Impact of clinical awareness and diagnostic tests on the underdiagnosis of Clostridium difficile infection.

Authors:  L Alcalá; E Reigadas; M Marín; A Martín; P Catalán; E Bouza
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-04-24       Impact factor: 3.267

2.  Age and gender differences in Clostridium difficile-related hospitalization trends in Madrid (Spain) over a 12-year period.

Authors:  M D Esteban-Vasallo; S Naval Pellicer; M F Domínguez-Berjón; M Cantero Caballero; Á Asensio; G Saravia; J Astray-Mochales
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-04-07       Impact factor: 3.267

3.  An outbreak of Clostridium difficile PCR ribotype 027 in Spain: risk factors for recurrence and a novel treatment strategy.

Authors:  E Bouza; L Alcalá; M Marín; M Valerio; E Reigadas; P Muñoz; M González-Del Vecchio; V de Egea
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-05-13       Impact factor: 3.267

4.  Indomethacin increases severity of Clostridium difficile infection in mouse model.

Authors:  Juan Muñoz-Miralles; Bruno C Trindade; Pablo Castro-Córdova; Ingrid L Bergin; Leslie A Kirk; Fernando Gil; David M Aronoff; Daniel Paredes-Sabja
Journal:  Future Microbiol       Date:  2018-09-21       Impact factor: 3.165

5.  Pseudomembranous colitis associated with a triple therapy for Helicobacter pylori eradication.

Authors:  Anca Trifan; Irina Girleanu; Camelia Cojocariu; Catalin Sfarti; Ana Maria Singeap; Carmen Dorobat; Lucia Grigore; Carol Stanciu
Journal:  World J Gastroenterol       Date:  2013-11-14       Impact factor: 5.742

6.  Clostridium difficile isolates with high linezolid MICs harbor the multiresistance gene cfr.

Authors:  Mercedes Marín; Adoración Martín; Luis Alcalá; Emilia Cercenado; Cristina Iglesias; Elena Reigadas; Emilio Bouza
Journal:  Antimicrob Agents Chemother       Date:  2014-11-10       Impact factor: 5.191

7.  High Prevalence of Toxigenic and Nontoxigenic Clostridium difficile Strains in Malaysia.

Authors:  Thomas V Riley; Deirdre A Collins; Rina Karunakaran; Maria Abdul Kahar; Ariza Adnan; Siti Asma Hassan; Nadiah Hanim Zainul; F R Mohammed Rustam; Z Abd Wahab; Ramliza Ramli; Yeong Yeh Lee; Hamimah Hassan
Journal:  J Clin Microbiol       Date:  2018-05-25       Impact factor: 5.948

8.  The emergence of Clostridium difficile PCR-ribotype 001 in Slovakia.

Authors:  O Nyc; M Krutova; A Liskova; J Matejkova; J Drabek; E J Kuijper
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-05-17       Impact factor: 3.267

9.  Epidemiology of Clostridium difficile infection and risk factors for unfavorable clinical outcomes: results of a hospital-based study in Barcelona, Spain.

Authors:  Dolors Rodríguez-Pardo; Benito Almirante; Rosa M Bartolomé; Virginia Pomar; Beatriz Mirelis; Ferran Navarro; Alex Soriano; Luisa Sorlí; Joaquín Martínez-Montauti; Maria Teresa Molins; Maily Lung; Jordi Vila; Albert Pahissa
Journal:  J Clin Microbiol       Date:  2013-02-27       Impact factor: 5.948

Review 10.  The prognostic value of toxin B and binary toxin in Clostridioides difficile infection.

Authors:  Salvador López-Cárdenas; Eva Torres-Martos; Juan Mora-Delgado; Juan Manuel Sánchez-Calvo; Marta Santos-Peña; Ángel Zapata López; María Dolores López-Prieto; Salvador Pérez-Cortés; Juan Carlos Alados
Journal:  Gut Microbes       Date:  2021-03-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.